...
首页> 外文期刊>World Journal of Surgery: Official Journal of the Societe Internationale de Chirurgie, Collegium Internationale Chirurgiae Digestivae, and of the International Association of Endocrine Surgeons >Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder.
【24h】

Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder.

机译:肝切除结合门静脉或肝动脉重建治疗晚期肝门胆管癌和胆囊癌。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hepatectomy with vascular reconstruction for biliary malignancy remains controversial. This study aimed to clarify the indications for surgery. Patients with advanced hilar bile duct cancer (HBDC) (n = 26) and gallbladder cancer (GBC) involving the hepatoduodenal ligament (n = 13) who underwent hepatectomy were enrolled. They were divided into two groups on the basis of whether vascular reconstruction was performed (HBDC, 10 yes vs. 16 no; GBC, 5 yes vs. 8 no). Portal vein (PV) reconstruction was performed on the right branch in seven patients and on the left branch in two; hepatic artery (HA) reconstruction was done on the right branch in 11 patients and on the left branch in 1. Five patients with HBDC and one with GBC underwent both PV and HA reconstruction. Patency rates were 88.0% and 83.3% for PV and HA reconstructions, respectively. Vascular reconstruction-related morbidity occurred in one patient with fatal liver failure owing to a portal thrombus and in two patients with multiple liver abscesses caused by arterial obstruction. Microsurgery eliminated reconstruction-related morbidity. Mortality in vascular reconstruction cases was 13.3% (2/15), and in those without reconstruction it was 8.3% (2/24). Curability rates (R0 and R1+R2) were 50.0% and 56.0% for HBDC and 40.0% and 62.5% for GBC, respectively. The 3-year survivals of HBDC patients were, respectively, 33% and 42%, and the 5-year survivals were 18% and 25%, whereas for GBC the 1-year survivals were 20% and 60% and the 2-year survivals 0% and 25%. Two patients with vascular involvement who underwent PV with HA reconstruction survived more than 3 years. Hepatectomy with vascular reconstruction for selected HBDC patients offers low surgical risk and increased survival by curable resection, but it is not recommended for advanced GBC.
机译:肝切除术与血管重建术治疗胆道恶性肿瘤仍存在争议。这项研究旨在阐明手术的适应症。参加肝切除术的晚期肝门胆管癌(HBDC)(n = 26)和胆囊癌(GBC)涉及肝十二指肠韧带(n = 13)的患者入组。根据是否进行了血管重建将他们分为两组(HBDC,10是vs. 16否; GBC,5是vs. 8否)。在7例患者的右分支和2例在左分支进行门静脉(PV)重建。分别在11例患者的右分支和1例左分支进行肝动脉(HA)重建。对5例HBDC和1例GBC患者进行了PV和HA重建。 PV和HA重建的通畅率分别为88.0%和83.3%。与血管重建相关的发病率发生在一名因门静脉血栓而致致命性肝衰竭的患者中,以及两名因动脉阻塞引起的多发肝脓肿的患者中。显微手术消除了与重建相关的发病率。血管重建病例的死亡率为13.3%(2/15),而未重建病例的死亡率为8.3%(2/24)。 HBDC的可治愈率(R0和R1 + R2)分别为50.0%和56.0%,GBC分别为40.0%和62.5%。 HBDC患者的3年生存率分别为33%和42%,5年生存率分别为18%和25%,而GBC的1年生存率分别为20%和60%,以及2年生存率生存率分别为0%和25%。两名接受PV重建并进行HA重建的血管受累患者存活超过3年。对于某些HBDC患者,肝切除和血管重建可以通过可治愈的切除术降低手术风险,并提高生存率,但是不建议用于晚期GBC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号